INOVIO to Participate in Upcoming Scientific and Investor Conferences

Rhea-AI Summary

INOVIO (NASDAQ:INO) announced participation in multiple scientific and investor conferences between Feb 18 and Mar 10, 2026. Management will present posters and talks on INO-3107, SARS-CoV-2 DMAbs phase 1 data, and hold investor fireside chats and one-on-one meetings.

Webcasts and replay links are provided for investor events; abstracts will be posted on the company website after each presentation.

News Market Reaction

-1.86%

1 alert

-1.86% News Effect

On the day this news was published, INO declined 1.86%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PLYMOUTH MEETING, Pa., Feb. 12, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following scientific and investor conferences:

American Association for Cancer Research Immuno-Oncology Conference (Los Angeles, CA)
Date: Wednesday, February 18
Time: 7:30-10 PM PT, Poster Session A
Poster Presentation: Treatment of RRP with DNA immunotherapy INO-3107 induces activation and enrichment of pro-inflammatory CD4+ T cell responses in blood and airways of patients with clinical response

Oppenheimer 36^th Annual Healthcare Life Sciences Conference (Virtual)
Date: Wednesday, February 25
Time: 12:40 -1:10 PM ET
Format: Fireside Chat
Webcast: https://event.summitcast.com/view/CTtthLh2Bi2D9aYoKpvtEv/degYsHNqjq4UMJYMr4minN

Festival of Biologics (San Diego, CA)
Date: Wednesday, March 4
Time: 3:10 PM PT
Presentation: Safety and Pharmacokinetics of SARS-CoV-2 DNA-Encoded Monoclonal Antibodies (DMAbs) in Healthy Adults: A Phase 1 Trial

Citizens Life Sciences Conference (Miami Beach, FL)
Date: Tuesday, March 10
Time: 1:40 – 2:05 PM ET
Format: Fireside Chat
Webcast: https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/j7XuLLN6VFvrBMcQmqB55w 

Available abstracts will be shared on INOVIO's website following presentations. Replay of the investor events will be available for 90 days at the links above and on the INOVIO events page. Members of INOVIO's management team will also be conducting one-on-one meetings with investors during the investor conferences.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. 

Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, investor.relations@inovio.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-scientific-and-investor-conferences-302685788.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

Which INOVIO (INO) scientific presentations are scheduled for February 2026?

INOVIO will present a poster on Feb 18 and a DMAb presentation on Mar 4. According to INOVIO, the Feb 18 poster (AACR IO) covers INO-3107 effects in RRP, and the Mar 4 talk reviews safety and PK of SARS-CoV-2 DNA-encoded monoclonal antibodies from a Phase 1 trial.

When and how can investors watch INOVIO (INO) at the Oppenheimer conference on Feb 25, 2026?

INOVIO will hold a virtual fireside chat on Feb 25 at 12:40 PM ET with a webcast link. According to INOVIO, the webcast is available live and replays of investor events will be accessible for 90 days via the provided links and the company events page.

What will INOVIO (INO) present about INO-3107 at the AACR Immuno-Oncology Conference?

The AACR poster on Feb 18 summarizes INO-3107 inducing pro-inflammatory CD4+ T cell activation in responders. According to INOVIO, the poster reports activation and enrichment of pro-inflammatory CD4+ T cell responses in blood and airways of patients with clinical response in RRP.

Will INOVIO (INO) provide replays of the investor conference webcasts and for how long?

Yes, investor event replays will be available for 90 days after each event. According to INOVIO, replay access is provided via the original webcast links and the INOVIO events page for investor review and follow-up.

Does INOVIO (INO) plan investor meetings during the March 2026 conferences?

Yes, INOVIO management will conduct one-on-one investor meetings during the investor conferences. According to INOVIO, management plans direct meetings in addition to scheduled fireside chats and webcasts to engage investors.

Where will INOVIO (INO) share abstracts and additional presentation materials from these conferences?

INOVIO will post available abstracts on its company website following each presentation. According to INOVIO, presentation abstracts will be shared on the INOVIO website after the conference sessions conclude.